Marketing authorization received for Lyfaquin(TM) (centhaquine) to treat patients with hypovolemic shock from Indian regulatory agency

Alembic Pharma gets USFDA nod for Tizanidine hydrochloride capsules used to treat spasticity.....»»

Raining USFDA warning letters to Indian drug sites point to intensified regulatory risk.....»»

Biocon"s co-developed insulin gets European nod for marketing.....»»

Mylan and Biocon receive approvals from European Commission.....»»

Cadila Healthcare gets Mexican regulatory nod to market Lipaglyn drug.....»»

Glenmark to unveil oral drug to treat psoriasis.....»»

Cadila Healthcare receives USFDA nod for two drugs.....»»

US regulatory nod for Zydus drug to treat dementia.....»»

GSK tests experimental drug to treat pneumonia from COVID-19.....»»

U.S. targets fraud in coronavirus antibody test market with tighter rules.....»»

Gilead gets US FDA#39;s emergency use authorisation for remdesivir.....»»

Gilead gets US FDA#39;s emergency use authorisation for remdevisir.....»»

Coronavirus | Why Gilead#39;s Remdesivir trial data is significant in fight against COVID-19.....»»

Coronavirus impact: Force Motors` mobile vans treat 1,11,679 patients in Maharashtra.....»»

#39;No evidence#39; that recovered COVID-19 patients cannot be reinfected: WHO.....»»

Coronavirus pandemic | Trump says he was #39;sarcastic#39; when talking about injecting disinfectants to treat COVID-19 patients.....»»

Dyson says UK government does not need its COVID-19 ventilator.....»»

Lysol maker urges people not to inject disinfectants after Trump remarks.....»»

NASA develops high-pressure ventilator to fight COVID-19.....»»

AstraZeneca pilots diabetes drug as potential COVID-19 treatment.....»»